EUVIMED · CrossrefJournal
Bleeding, Thrombosis and Vascular Biology
ISSN 2785-5309 · PAGEPress Publications
Latest articles
CO105 | THALIDOMIDE FOR RECURRENT GASTROINTESTINAL BLEEDING IN RARE BLEEDING DISORDERS AND VENOUS MALFORMATIONS: A MONOCENTRIC EXPERIENCE
CO108 | MECHANOCHEMICAL REPROGRAMMING OF VWF–GPIB INTERACTIONS UNCOUPLES AFFINITY FROM AVIDITY AND LINKS THROMBOCYTOPENIA TO ANGIODYSPLASIA IN TYPE 2B VON WILLEBRAND DISEASE
CO109 | THE ROLE OF SELECTED LDLR AND LRP1 VARIANTS IN MODULATING LDL AND FVIII LEVELS IN METABOLIC SYNDROME
CO110 | FLOW-BASED WHOLE-BLOOD THROMBUS PROFILING DISCRIMINATES ANTITHROMBOTIC DRUG EFFECTS AND UNCOVERS PLATELET-DEPENDENT COAGULATION DEFECTS AFTER CARDIOPULMONARY BYPASS
PO005 | EXTENDED ANTICOAGULATION WITH DOACS IN PATIENTS AFFECTED BY HEMATOLOGIC MALIGNANCIES AND VENOUS THROMBOEMBOLISM: DOES LOW DOSE FIT ALL?
PO014 | DETERGENT AND GANGLIOSIDE GM1-BINDING PROPERTIES OF PLATELET FACTOR 4 AS ASSESSED BY CHARGE-SHIFT ELECTROPHORESIS
PO018 | IS VESSEL-ON-CHIP COMPLEXITY WORTH IT? A QUANTITATIVE COMPARISON OF SIMPLIFIED AND COMPLEX HIGH-FIDELITY VASCULAR MODELS
PO024 | IMPLEMENTATION OF 4PL SIGMOIDAL REGRESSION FOR FACTOR VIII INHIBITOR QUANTIFICATION IN ACQUIRED HEMOPHILIA
PO025 | CHARACTERIZATION OF PLATELET DYSFUNCTION IN NOONAN SYNDROME PATIENTS
PO029 | IMPACT OF HEPATOCELLULAR CARCINOMA ON CIRCULATING RETICULATED PLATELETS IN PATIENTS WITH AND WITHOUT LIVER CIRRHOSIS
PO032 | INHIBITION OF PLATELET ACTIVATION BY SMALL MOLECULE SYNTHETIC AGONISTS OF THE BILE ACID RECEPTOR: A NOVEL APPROACH TO ANTIPLATELET THERAPY
PO033 | PLATELET COUNT AND PERIPROCEDURAL MAJOR BLEEDING IN CIRRHOTIC PATIENTS UNDERGOING INVASIVE PROCEDURES: INDIVIDUAL PATIENT DATA META-ANALYSIS
PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY?
PO061 | LONG-TERM HEADACHE IMPROVEMENT WITH VITAMIN K ANTAGONISTS IN PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME: 2-YEAR OBSERVATIONAL COHORT
PO062 | AN AUTOMATED LABORATORY ALERT ALGORITHM FOR EARLY IDENTIFICATION OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN THE EMERGENCY SETTING
PO063 | EVALUATION OF PLATELET ACTIVATION MARKERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
PO116 | MONOCENTRIC EXPERIENCE OF DOACS REVERSAL MANAGEMENT AT L SACCO HOSPITAL, MILAN: A REAL-WORLD RETROSPECTIVE STUDY
PO118 | VARIATION OF EGFR IN PATIENT IN DOACS THERAPY
PO125 | ROMIPLOSTIM FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN ADVANCED SOLID TUMORS: A SINGLE-CENTER EXPERIENCE
PO127 | ANAPHYLACTIC REACTION TO RECOMBINANT ACTIVATED FVII IN A MILD HEMOPHILIA A PATIENT WITH INHIBITOR: A CASE REPORT
PO128 | FROM SEVERE THROMBOSIS TO SUCCESSFUL PREGNANCIES: ORTHOTOPIC LIVER TRANSPLANTATION IN INHERITED AFIBRINOGENEMIA WITH BUDD–CHIARI SYNDROME
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Artificial intelligence and machine learning in hemostasis and thrombosis
Inflammation, platelets and diabetes
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review
Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results
The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice
EUVIMED